These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9762413)

  • 21. Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venom of Trimeresurus albolabris: significance for the expression of platelet aggregation inhibitory activity.
    Calvete JJ; Schäfer W; Soszka T; Lu WQ; Cook JJ; Jameson BA; Niewiarowski S
    Biochemistry; 1991 May; 30(21):5225-9. PubMed ID: 2036389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
    Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
    Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation.
    Jeon OH; Kim D; Choi YJ; Kim SH; Choi WS; Kim DS
    Thromb Res; 2007; 119(5):609-19. PubMed ID: 16797059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triflavin inhibits platelet-induced vasoconstriction in de-endothelialized aorta.
    Sheu JR; Yen MH; Hung WC; Lee YM; Su CH; Huang TF
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3461-8. PubMed ID: 9437193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
    Chiang HS; Yang RS; Huang TF
    Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the role of proline residues flanking the RGD motif of dendroaspin, an inhibitior of platelet aggregation and cell adhesion.
    Lu X; Sun Y; Shang D; Wattam B; Egglezou S; Hughes T; Hyde E; Scully M; Kakkar V
    Biochem J; 2001 May; 355(Pt 3):633-8. PubMed ID: 11311124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric derivative of fibrolase, a fibrinolytic enzyme from southern copperhead venom, possesses inhibitory activity on platelet aggregation.
    Swenson S; Bush LR; Markland FS
    Arch Biochem Biophys; 2000 Dec; 384(2):227-37. PubMed ID: 11368309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].
    Udrardy M; Schwartzott D; Jackson K; McKee PA
    Orv Hetil; 1995 Jan; 136(3):129-33. PubMed ID: 7870410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of arginine-glycine-aspartate-containing peptides as inhibitors of equine platelet function.
    Weiss DJ; Evanson OA; Wells RE
    Am J Vet Res; 1997 May; 58(5):457-60. PubMed ID: 9140550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arg-Tyr-Asp (RYD) and Arg-Cys-Asp (RCD) motifs in dendroaspin promote selective inhibition of beta1 and beta3 integrins.
    Wattam B; Shang D; Rahman S; Egglezou S; Scully M; Kakkar V; Lu X
    Biochem J; 2001 May; 356(Pt 1):11-7. PubMed ID: 11336631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of RGD-containing peptides on platelet aggregation].
    Vasil'eva TM; Makarov VA; Petrukhina GN; Voiushina TL; Iusupova MP; Novgorodova SA; Kotlova EK
    Eksp Klin Farmakol; 2006; 69(4):39-42. PubMed ID: 16995437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
    Okuda D; Morita T
    J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence.
    Jing J; Lu S
    Biotechnol Lett; 2005 Sep; 27(17):1259-65. PubMed ID: 16215822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
    J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
    Foster MR; Hornby EJ; Brown S; Hann M; Kitchin J; Pike N; Ward P
    Thromb Res; 1994 Aug; 75(3):269-84. PubMed ID: 7992238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-adhesive and anti-thrombotic effects of integrin-inhibiting tripeptides (Arg-Gly-Asp)].
    Udvardy M
    Orv Hetil; 1995 Oct; 136(40):2155-9. PubMed ID: 7566948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis.
    Udvardy M; Schwartzott D; Jackson K; McKee PA
    Blood Coagul Fibrinolysis; 1995 Feb; 6(1):11-6. PubMed ID: 7795148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Purification and characterization of a kringle-deficit mutant of human plasminogen with Arg-Gly-Asp tripeptide expressed in Pichia pastorsis].
    Chen W; Wu M; Wu J; Yang J; Chen Z; Huang Z; Zhang X; Xiao Y
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):764-72. PubMed ID: 21845843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro fibrinolysis and antithrombosis characterizations of novel recombinant microplasminogen with RGD and GPRP peptides.
    Chen W; Li Y; Chen P; Wu M; Wang L; Zhang H; Wang L
    J Thromb Thrombolysis; 2016 Jul; 42(1):118-26. PubMed ID: 26814674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.